Table 2 Clinical characteristics of the metastatic RCC unselected cases with pathogenic germline variants.
From: Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma
Characteristic | No germline pathogenic variant, n = 275 | Germline pathogenic variant in RCC predisposition gene, n = 4 | Germline pathogenic variant in other cancer-related gene, n = 15 | ||
---|---|---|---|---|---|
n (%) | n (%) | p valuea | n (%) | p valuea | |
Age at RCC diagnosis, years | |||||
Median [IQR] (min, max) | 60 [51–69] (20, 87) | 42 [39–49] (36, 64) | 0.036 | 56 [50–66] (36, 70) | 0.25 |
Sex | |||||
Male | 180 (66) | 2 (50) | 0.51 | 14 (93) | 0.026 |
Female | 94 (34) | 2 (50) | 1 (7) | ||
RCC histologyb | |||||
Clear cell | 212 (77) | 1 (25) | 0.0025 | 13 (87) | 0.34 |
Non–clear cell | 43 (16) | 3 (75) | 1 (7) | ||
Papillary | 21 (8) | 3 (75) | 4.9×10−6 | 1 (7) | 0.89 |
Chromophobe | 15 (5) | 0 (0) | 0.79 | 0 (0) | 0.44 |
Other | 7 (3) | 0 (0) | 0.90 | 0 (0) | 0.69 |
Unknown | 20 (7) | 0 (0) | – | 1 (7) | – |
Metastasis | |||||
At diagnosis | 87 (37) | 2 (50) | 0.59 | 6 (40) | 0.80 |
At diagnosis or in <6 months | 123 (52) | 2 (50) | 0.94 | 6 (40) | 0.37 |
History of cancers | |||||
Personal history in cancer/in RCC | 14 (9)/3 (2) | 1 (33)/1 (33)c | 0.16/6.9×10−4 | 1 (11)/0 (0) | 0.85/0.84 |
Family history in cancer/in RCC | 21 (18)/4 (3) | 3 (100)/1 (33)c | 0.0070/0.011 | 3 (60)/0 (0) | 0.020/0.87 |